REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 22 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,336,000 | 1.60% |
| Context Capital Management, LLC | 6,000 | $6,920,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,155,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,445,000 | $6,268,000 | 0.05% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,445,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,000,000 | $17,301,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 25,500,000 | $29,411,000 | 0.03% |
| Citadel Advisors | 124,954,000 | $143,872,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $55,363,000 | 0.02% |
| AVIVA PLC | 3,900,000 | $4,479,000 | 0.02% |